Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cyanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel iridium catalyzed route offers high yield cyanophenyl compounds. Reduces costs and improves supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Novel green synthesis of beta-cyano ketones using acetone cyanohydrin. High yield, low toxicity, scalable process for pharmaceutical intermediates.
Patent CN103619815A details a high-yield four-step synthesis for proline compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1293942C reveals a robust Ni(0) catalyst system using metallic nickel powder for efficient adiponitrile synthesis, offering significant cost and stability advantages.
Novel cyanation method using DMF and ammonium iodide ensures safe scalable production of high-purity pharmaceutical intermediates with reduced environmental impact.
Patent CN106518839A enables safe 2-thiopheneacetic acid production. High purity pharmaceutical intermediates with reduced toxic waste and scalable manufacturing processes.
Patent CN110092753B reveals a high-yield 4-step synthesis for 3-azabicyclo[4.1.0]heptane-2-carboxylic acid, offering significant cost reduction and scalable supply chain solutions.
Patent CN102381918A details a safe copper-catalyzed route to benzyl cyanides using potassium ferrocyanide, offering significant cost and safety advantages for supply chains.
Novel cyanation patent CN110437262A enables safer pharmaceutical intermediate manufacturing with reduced toxicity and improved supply chain reliability for global buyers.
Patent CN102603566B details a room-temperature asymmetric synthesis of chiral amino nitriles using copper catalysis, offering mild conditions for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed regioselective 1,4-sulfocyanation for efficient allene nitrile production. Reduces steps and cost for API manufacturing.
Patent CN119912513A reveals a novel route for Zuranolone intermediates eliminating chromatography. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Novel patent CN114805360B details safer temozolomide preparation avoiding toxic reagents, ensuring high purity and supply chain stability for pharmaceutical manufacturing.
Novel copper-catalyzed cyanation method offers mild conditions and high yields for anti-inflammatory intermediates, ensuring reliable supply chain stability.
Patent CN102358715B details a low-toxicity cyanation method using potassium ferrocyanide, offering significant cost reduction and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN114539097B reveals a mild Pd-catalyzed cyanation of sulfonium salts. This method offers reliable supply chain solutions and cost reduction in pharmaceutical intermediate manufacturing.
Novel oxidation-cyanation-hydrolysis route for 3-bromo-6-chloropyridine formamide. Cost-effective, scalable process for bromodomain inhibitor intermediates.
Patent CN113072470A reveals a mild Cu-catalyzed synthesis for N-acetonitrile bis-benzenesulfonylimine derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel synthesis route for Sulpiride intermediate. Mild conditions, high purity. Reliable pharmaceutical intermediate supplier for global supply chains.
Novel catalyst-free method for 3-selenocyanoindoles using elemental selenium. High yields, scalable process for pharmaceutical and agrochemical manufacturing.